Organisation/Company Università degli Studi di Verona Research Field Biological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 31 Aug 2026 - 13:00 (UTC) Country Italy Type
Università degli Studi di Verona invites applications for a research position focused on microalgae and cyanobacteria, with responsibilities spanning isolation, characterization, and optimization of cultivation conditions in lab-scale systems and photobioreactors. The work integrates metabolic profiling and
Italy Job Info Job Identification 22711 Posting Date 08/19/2026, 10:44 AM Apply Before 09/02/2026, 09:59 PM Contract Type Fixed-term (1 year with possibility of extension) Org Type Country Office Vacancy Type Vacancy Notice Grade G-4 Is
Job Description Golden Goose is a journey of love and authenticity, leading you to embrace your true self, where tradition and innovation merge into timeless, one-of-a-kind creations. DESCRIPTION We are looking for a passionate talent to
AGAP2 è un gruppo europeo di consulenza ingegneristica e operativa facente parte del Gruppo MoOngy. Per un importante progetto in ambito FinTech, siamo alla ricerca di un Senior Java Developer da inserire allinterno di un team
Job Description Golden Goose is a journey of love and authenticity, leading you to embrace your true self, where tradition and innovation merge into timeless, one‑of‑a‑kind creations. Description We are looking for a passionate talent to
Human Technopole in Milan invites applications for a joint appointment between the Functional Genomics and Molecular Cell Biology Research Centres. The project investigates RNA localization and translation in ciliogenesis, using transcriptomics, ribosome profiling, proteomics and cryo-EM. You
Build the science that shapes the future of human health. Application closing date: 24.08.2026 Human Technopole (Milan) is a rapidly expanding life science institute where international researchers and cutting-edge technologies converge to accelerate biomedical discovery. Our